Mayne slides to two-and-a-half year low as generics take toll
MELBOURNE: Specialty pharmaceutical company Mayne Pharma is the biggest loser among the top 200 stocks,
MELBOURNE: Specialty pharmaceutical company Mayne Pharma is the biggest loser among the top 200 stocks,
FEATURED
Boomer turned 1000 straw bales into a fortress-like house
Virtual reality deployed to support assisted living residents
Best affordable seniors housing design for Global Awards shortlisted
15-story Asian senior housing tower project up for review
First Nations entity moves into build-to-rent market
Office building to be converted into seniors housing community
INNOVATION
